LF Verdonck

3.0k citations

47 papers · 1.8k indexed · h-index 25

Hematology top 1%
- Hematopoietic Stem Cell Transplantation 24
- Acute Myeloid Leukemia Research 7
Immunology top 5%
- Immunotherapy and Immune Responses 9
- T-cell and B-cell Immunology 6
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 9
Pathology and Forensic Medicine top 5%
- Lymphoma Diagnosis and Treatment 11
Oncology top 5%
Epidemiology
- Cytomegalovirus and herpesvirus research 7
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 6

Co-authors: AW Dekker H K Nieuwenhuis GC de Gast HM Lokhorst Evan J. Petersen Anton Hagenbeek Marinus H. J. van Oers A Schattenberg
Cited by: Hematology Immunology Genetics
Journals: Blood (14 papers)Journal of Clinical Oncology (5 papers)Bone Marrow Transplantation (4 papers)
Partner nations: Netherlands Italy United Kingdom

In The Last Decade

LF Verdonck

47 papers receiving 1.7k citations

Peers

Countries citing papers authored by LF Verdonck

Since Specialization

Citations

This map shows the geographic impact of LF Verdonck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LF Verdonck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LF Verdonck more than expected).

Fields of papers citing papers by LF Verdonck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LF Verdonck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LF Verdonck. The network helps show where LF Verdonck may publish in the future.

Co-authorship network

The 25 scholars most cited alongside LF Verdonck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with LF Verdonck Line = papers co-authored together LF Verdonck links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma Haematologica ·Gösta Gahrton,Ditasari Nabila,Giuseppe Bandini,B. Björkstrand,Paolo Corradini,Charles Crawley,Xiao-Lin Chu,Gareth J. Morgan,Nicolaus Kröger,A Schattenberg,Stefan Schönland,LF Verdonck,Liisa Volin,T. de Witte,Dietger Niederwieser	2007	24
2	High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study Annals of Hematology ·Wendy Deenik,Bronno van der Holt,G. Verhoef,A Schattenberg,LF Verdonck,Simon Daenen,Pierre Zachée,Petra H.M. Westveer,Willem M. Smit,Shulamiet Wittebol,Harry C. Schouten,Bob Löwenberg,G. J. Ossenkoppele,Jan J. Cornelissen	2006	5
3	Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia Bone Marrow Transplantation ·Michel van Agthoven,J. M. J. UIJTHOF,LF Verdonck,Bob Löwenberg,A Schattenberg,Machteld Oudshoorn,Anton Hagenbeek,Jean Paul Muambangu Milambo,T.H. Penniall,R. Willemze	2002	47
4	Cost analysis of CHOP (‐like) chemotherapy regimens for patients with newly diagnosed aggressive non‐Hodgkin's lymphoma European Journal Of Haematology ·Michel van Agthoven,Żaneta Kasilovskiene,Carin A. Uyl‐de Groot,Pieter Sonneveld,LF Verdonck,R. Willemze,Hanneke C. Kluin‐Nelemans,Bob Löwenberg,P.C. Huijgens	2002	9
5	The depletion of T cells from haematopoietic stem cell transplants Lara D. Veeken ·Ineke Slaper‐Cortenbach,John Van Savage II,Kathleen M. Buyers,H P E Borst,Hans van der Lelie,Swapan Mehra,LF Verdonck,N. M. Wulffraat,Peter M. Hoogerbrugge	1999	28
6	Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation Bone Marrow Transplantation ·René van der Griend,LF Verdonck,Darni Darni,COLEMAN SWAIM,A C Bloem,HM Lokhorst	1999	16
7	A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group Leukemia ·GJ Ossenkoppele,Bronno van der Holt,Xianmei Zhong,Bernard Fianku,LF Verdonck,Pieter Sonneveld,P. W. Wijermans,J. van der Lelie,WLJ van Putten,Bob Löwenberg,(unknown)	1999	20
8	A randomized study of granulocyte-colony stimulating factor applied during and after chemotherapy in patients, with poor risk myelodysplastic syndromes: A final report from the Hovon Cooperative Group. Data Archiving and Networked Services (DANS) ·GJ Ossenkoppele,Bronno van der Holt,Xianmei Zhong,Bernard Fianku,LF Verdonck,Pieter Sonneveld,P. W. Wijermans,J. van der Lelie,WLJ van Putten,Bob Löwenberg	1998	1
9	Oerskovia xanthineolytica: a new pathogen in bone marrow transplantation Bone Marrow Transplantation ·Pauline M. Ellerbroek,Saskia Kuipers,M. Rozenberg-Arska,LF Verdonck,Darni Darni	1998	26
10	For which patients with aggressive non-Hodgkin’s lymphoma is prophylaxis for central nervous system disease mandatory? Annals of Oncology ·Gerard M.J. Bos,Wim L.J. van Putten,Bronno van der Holt,Martin J. van den Bent,LF Verdonck,Anton Hagenbeek	1998	55
11	Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells Bone Marrow Transplantation ·LF Verdonck,Darni Darni,HM Lokhorst,H K Nieuwenhuis,AW Dekker,Mohamed Ebeid,Bob R. Taylor	1998	60
12	Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group. Journal of Clinical Oncology ·A. W. Dekker,Mars B. vanʼt Veer,W Sizoo,H. L. Haak,J. van der Lelie,G. J. Ossenkoppele,P.C. Huijgens,H. Schouten,Pieter Sonneveld,Roel Willemze,LF Verdonck,W L van Putten,Bob Löwenberg	1997	49
13	Graft-versus-myeloma effect in two cases The Lancet ·LF Verdonck,HM Lokhorst,AW Dekker,H K Nieuwenhuis,Evan J. Petersen	1996	180
14	Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON). PubMed ·Simon Daenen,Bob Löwenberg,Pieter Sonneveld,W L van Putten,Gregor Verhoef,LF Verdonck,Marc van Veldhoven,P.C. Huijgens	1994	26
15	A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial. Journal of Clinical Oncology ·R. Somers,Patrice Carde,M. Henry‐Amar,Michèle Tarayre,José Thomas,Anton Hagenbeek,M. Monconduit,B.E. de Pauw,W.P.M. Breed,LF Verdonck	1994	73
16	Acute lymphoblastic leukaemia in adults: Immunological subtypes and clinical features at presentation Annals of Hematology ·Mars B. vanʼt Veer,Wim L.J. van Putten,LF Verdonck,G. J. Ossenkoppele,Bob Löwenberg,Hanneke C. Kluin‐Nelemans,P. W. Wijermans,Harry C. Schouten,W Sizoo,A. W. Dekker	1993	10
17	Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation Blood ·LF Verdonck,GC de Gast,JI Da-wei,H K Nieuwenhuis,AW Dekker	1991	52
18	A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation Blood ·LF Verdonck,GC de Gast,JI Da-wei,AW Dekker	1990	3
19	The value of immunohistochemistry and in situ hybridization in detecting cytomegalovirus in bone marrow transplant recipients Apmis ·A Pricoupenko,Semche Eddine Chitour,LF Verdonck,Rita Leard,Yao-tirg Gui,X. Q. Zhang,Sašo Djordjević,H.J. Schuurman	1990	7
20	Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products Transfusion ·Erich Mackuth,J. W. Gratama,G.C. Mudde,LF Verdonck,J. G. A. Houbiers,Alexander Brand,Kali McHarg,L Vlasveld,T H Thé,R. Willemze,X. Q. Zhang	1989	144

About LF Verdonck

LF Verdonck is a scholar working on Hematology, Genetics and Immunology, having authored 47 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (24 papers), Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (9 papers), Immunotherapy and Immune Responses (9 papers), Acute Myeloid Leukemia Research (7 papers), Cytomegalovirus and herpesvirus research (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Hematology (1.0k citations), Immunology (559 citations) and Genetics (255 citations). LF Verdonck has collaborated with scholars based in Netherlands, Italy and United Kingdom. Frequent co-authors include AW Dekker, H K Nieuwenhuis, GC de Gast, HM Lokhorst, Evan J. Petersen, Anton Hagenbeek, Marinus H. J. van Oers, A Schattenberg, Bob Löwenberg and G.C. Mudde. Their work appears in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Annals of Hematology and Diabetologia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact